Delivery Order SPE2DB20D1100-SPE2DB24FA9P9
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has an award value of $7,054.40 and a period of performance through May 1, 2024. It is for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a potential value of $7,054.40 and a completion date of February 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a potential value of $2,821.76 and a completion date of March 19, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit corporation Amerisourcebergen Corporation. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a specialty pharmaceutical product, with a potential value of $10,581.60 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a ceiling value of $5,290.80 and a completion date of June 13, 2024. Amerisourcebergen is a major pharmaceutical distribution company that provides a wide range of medications, medical devices, and supplies to various federal agencies, including the Department of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $21,163.20 order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceuticals to support DLA Troop Support Medical facilities. This is one of many such delivery orders Amerisourcebergen Drug Corp has received from DLA to provide pharmaceuticals...
- The Defense Logistics Agency awarded a $7,691.00 delivery order to AmerisourceBergen Drug Corp for GEL-ONE 30 mg/3 ml syringes (3 ml quantity) with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this order is $5,290.80, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside contract. This award is part of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a ceiling value of $21,163.20 and a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA9P9Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation. The $21,163.20 delivery order is for GEL-ONE 30 MG/3 ML SYRINGE 3ML, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical in support of the Department of Defense. The current delivery order was not set aside for any specific business type. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and distribution services for military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 3/26/24 |